MERCAPTOPURINE TABLETS USP

Product Overview

About MERCAPTOPURINE TABLETS USP

MERCAPTOPURINE TABLETS USP is a prescription medication containing the active ingredient MERCAPTOPURINE, used in the treatment of acute lymphocytic leukemia (ALL) and certain cases of chronic myeloid leukemia (CML). It belongs to a class of medications known as purine analogs, which work by interfering with the production of DNA and RNA in cancer cells.

Key Benefits & Uses

• Treatment of acute lymphocytic leukemia (ALL)
• Treatment of certain cases of chronic myeloid leukemia (CML)
• Induction of remission in patients with ALL

Active Ingredient & Action

MERCAPTOPURINE works by inhibiting the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT), which is involved in the synthesis of purine nucleotides. This leads to the accumulation of toxic metabolites, which ultimately cause DNA damage and cell death in rapidly dividing cancer cells.

Important Notes

MERCAPTOPURINE TABLETS USP should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration schedule to minimize the risk of adverse effects. Patients taking MERCAPTOPURINE should be closely monitored for signs of bone marrow suppression, liver toxicity, and other potential side effects.